Pear Therapeutics Inc
NASDAQ:PEAR
Pear Therapeutics Inc
Cash from Financing Activities
Pear Therapeutics Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
Pear Therapeutics Inc
NASDAQ:PEAR
|
Cash from Financing Activities
$2.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Veeva Systems Inc
NYSE:VEEV
|
Cash from Financing Activities
-$16.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash from Financing Activities
$14m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Cash from Financing Activities
$281.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Cash from Financing Activities
-$74.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Cash from Financing Activities
-$167.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
See Also
What is Pear Therapeutics Inc's Cash from Financing Activities?
Cash from Financing Activities
2.2m
USD
Based on the financial report for Dec 31, 2022, Pear Therapeutics Inc's Cash from Financing Activities amounts to 2.2m USD.
What is Pear Therapeutics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-99%
Over the last year, the Cash from Financing Activities growth was -99%.